Cargando…
Bypassing the Blood–Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies
Epilepsies are common chronic neurological diseases characterized by recurrent unprovoked seizures of central origin. The mainstay of treatment involves symptomatic suppression of seizures with systemically applied antiseizure drugs (ASDs). Systemic pharmacotherapies for epilepsies are facing two ma...
Autores principales: | Gernert, Manuela, Feja, Malte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760299/ https://www.ncbi.nlm.nih.gov/pubmed/33255396 http://dx.doi.org/10.3390/pharmaceutics12121134 |
Ejemplares similares
-
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
por: Lee, David, et al.
Publicado: (2021) -
Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics
por: WANG, KAI, et al.
Publicado: (2022) -
Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021) -
Intraosseous administration into the skull: Potential blood–brain barrier bypassing route for brain drug delivery
por: Kang, Ji Hee, et al.
Publicado: (2022) -
Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
por: Teleanu, Raluca Ioana, et al.
Publicado: (2022)